← Eichor
Condition: Febrile Neutropenia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Febrile Neutropenia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Short Antibiotic Treatment in High Risk Febrile Neutropenia
NA · 4 location(s) · University Health Network, Toronto · NCT05786495Next-Generation-Sequencing Approach to Neutropenic Sepsis
Phase N/A · 6 location(s) · Boris Böll · NCT05815628Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy
Phase 2 · 1 location(s) · Affiliated Hospital of Nantong University · NCT07205536Phase II Study of QLC2519 in Pediatric Solid Tumor Participants
Phase 2 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT07724756Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients
NA · 1 location(s) · Valeria Cento · NCT07372131Early De-escalation of Empirical Antibiotics Treatment for Neutropenic Fever
NA · 1 location(s) · Shanghai Jiao Tong University School of Medicine · NCT04270786Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints
Phase 4 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT06616571Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients.
Phase N/A · 1 location(s) · Shanxi Bethune Hospital · NCT07204522Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Maligna
Phase 4 · 1 location(s) · Gadjah Mada University · NCT07016165Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia
Phase N/A · 3 location(s) · Instituto de Investigación Biomédica de Salamanca · NCT07277387Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With
Phase 4 · 1 location(s) · Beneficência Portuguesa de São Paulo · NCT06342115Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapi
NA · 2 location(s) · Peter MacCallum Cancer Centre, Australia · NCT07051525The Ambient Light Multiple Myeloma Study
NA · 2 location(s) · Icahn School of Medicine at Mount Sinai · NCT05737732Stopping Antibiotics After 3 Days for the Treatment of High-risk FEbrile Neutropenia
Phase 4 · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT05926063Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropen
Phase 2 · 1 location(s) · Henan Cancer Hospital · NCT07187908Adjustment of Antibiotic Dosage in Pediatric Oncology Patients With Febrile Neutropenia and Augmented Renal Clearance
Phase 4 · 1 location(s) · Centre Hospitalier Universitaire Vaudois · NCT06293677
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.